Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-053064

Chief Executive Officer sold 56,325 shares at $31.83 ($1,792,825)

  • Chief Executive Officer acquired 56,325 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2019-10-10 Option exercise +56,325 $5.20 $292,890 2,178,228 D
Anzalone Christopher Richard Chief Executive Officer 2019-10-10 Sale −56,325 $31.83 $1,792,825 2,121,903 D
Derivatives
Anzalone Christopher Richard Chief Executive Officer 2019-10-10 Option exercise · Stock Option (right to buy) −56,325 945,543 D
Open-market sales · 56,325 sh · avg $31.83 · $1,792,825
Loading xslF345X03/doc4.xml…